Of note, it has been reported that RACGAP1 is overexpressed and associated with shorter overall survival in multiple malignances, including cancers of liver, gallbladder, breast, bladder and prostate [26, 28, 43–45]. The gene discussed is RACGAP1; the disease is liver cancer.